EUVIMEDEUVIMED entdecken
Crossref

A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han Rats

Chitrang R Shah, Sandip B Patel iD, Vishal J Patel, Hardikkumar H Savsani, Amit A Joharapurkar, Urvit P Patel, Jitendra H Patel, Ramchandra K Ranvir, Rajesh Sundar, Mukul R Jain

International Journal of Toxicology · 2026

DOI: 10.1177/10915818251374566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Toxicology, 2026. Verfasst von Chitrang R Shah und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, India. Hauptthemen laut MEDLINE: Benzoates, Benzimidazoles, Pyrazines, Triazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes and hypertension often coexist and need complex pharmacological management. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, is widely used for glycemic control, and telmisartan, an angiotensin II receptor blocker, is the preferred treatment for hypertension. Thus, we have conducted a 1-month exploratory combination safety and toxicity study in male Wistar Han rats. Animals were administered 100 mg/kg/day of sitagliptin or telmisartan individually, or in combination by oral gavage. We have evaluated effects on body weight, feed intake, clinical chemistry, and hematology parameters, and microscopic examination of liver, kidney, adrenal glands, heart, lungs, lymphatic organs, and gastrointestinal tract. The combination showed a decrease in body weight gain, feed intake, hematocrit, reticulocytes, WBCs, serum triglycerides, AST, total protein, globulin, and heart weight, and increased serum levels of urea, phosphorous, magnesium, potassium, and kidney weight. Co-administration showed an additive effect on decrease in WBC counts, potentiating the effects on decreased serum triglycerides and increased phosphorous levels and kidney weights, and a synergistic effect on serum AST levels. Sitagliptin attenuated the changes caused by telmisartan on reticulocyte counts, serum creatinine levels, and liver and thymus weights. Administration of the individual compounds caused a reduction in spleen weight, though the combination had no effect. Sitagliptin, telmisartan, or combination dosing showed no significant organ toxicity upon histopathological examination. It appears that co-administration of telmisartan and sitagliptin is well tolerated in rats. Three-month toxicity studies, in both genders, with full toxicokinetic profiling and thorough tissue examination, will be necessary to support the combination’s toxicity profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzoatesBenzimidazolesPyrazinesTriazolesAngiotensin II Type 1 Receptor BlockersHypoglycemic AgentsAnimalsMaleTelmisartanSitagliptin PhosphateRatsRats, WistarOrgan SizeBody WeightKidney

Stichwörter der Autor:innen

combinationsafetysitagliptintelmisartantoxicity

Substanzen

TelmisartanSitagliptin PhosphateBenzoatesBenzimidazolesPyrazinesTriazolesAngiotensin II Type 1 Receptor BlockersHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, India.
  • Graduate School of Pharmacy, Gujarat Technological University, Gandhinagar, India.
  • Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, India.

ORCID-Profile: Sandip B Patel

Zitieren

APA

Shah, C. R., Patel, S. B., Patel, V. J., Savsani, H. H., Joharapurkar, A. A., Patel, U. P., Patel, J. H., Ranvir, R. K., Sundar, R., & Jain, M. R. (2026). A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han Rats. International Journal of Toxicology. https://doi.org/10.1177/10915818251374566

Vancouver

Shah CR, Patel SB, Patel VJ, Savsani HH, Joharapurkar AA, Patel UP, et al. A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han Rats. International Journal of Toxicology. 2026. doi:10.1177/10915818251374566

BibTeX
@article{Shah2026,
  author = {Shah, Chitrang R and Patel, Sandip B and Patel, Vishal J and Savsani, Hardikkumar H and Joharapurkar, Amit A and Patel, Urvit P and Patel, Jitendra H and Ranvir, Ramchandra K and Sundar, Rajesh and Jain, Mukul R},
  title = {A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han Rats},
  journal = {International Journal of Toxicology},
  year = {2026},
  doi = {10.1177/10915818251374566}
}
Kostenlos starten →